Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3397750 | 0.76 | CYP1A2 (0.58) | APPALDH1A1FFAR1FFAR4CYP1A2 | |
| SCHEMBL3888886 | 0.73 | CALM1 (0.50) | CALM1APPTSHRALDH1A1LOXL2 | |
| SCHEMBL219176 | 0.73 | ALDH1A1 (0.53) | CALM1TSHRALDH1A1LOXL2IDO1 | |
| SCHEMBL1453870 | 0.70 | CALM1 (0.41) | CALM1APPTSHRALDH1A1LOXL2 | |
| SCHEMBL269027 | 0.69 | — | — | |
| SCHEMBL10672679 | 0.69 | — | — | |
| SCHEMBL9856631 | 0.69 | CALM1 (0.45) | CALM1APPTSHRALDH1A1LOXL2 | |
| SCHEMBL16207396 | 0.69 | — | — | |
| SCHEMBL97491 | 0.69 | — | — | |
| SCHEMBL1332411 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | claimed |
| US-20190177469-A1 | CURABLE RESIN COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2019-06-13 | — | — | US | claimed |
| EP-1808912-B1 | Electron transport compound and organic light emitting device comprising the same | LG DISPLAY CO LTD (KR) | 2012-08-15 | — | — | EP | claimed |
| US-20070244319-A1 | Metallocenyl P-N ligands, preparation thereof, and use for asymmetric catalysis | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2007-10-18 | — | — | US | claimed |
| US-20070167626-A1 | Electron transport compound and organic light emitting device comprising the same | LG ELECTRONICS INC. | 2007-07-19 | — | — | US | claimed |
| EP-1808912-A2 | Electron transport compound and organic light emitting device comprising the same | LG Electronics Inc. (KR) | 2007-07-18 | — | — | EP | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0830395-A1 | PROCESS FOR PREPARING AND USING A SUPPORTED METALLOCENE-ALUMOXANE CATALYST | FINA RESEARCH S.A. (BE) | 1998-03-25 | — | — | EP | claimed |
| EP-0158809-B1 | ELECTRICAL INSULATING OIL AND OIL-FILLED ELECTRICAL APPLIANCES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1989-01-25 | — | — | EP | claimed |
| EP-0299313-A1 | Pesticide based or derivatives of 2,3-diaminomaleonitrile | BAYER AG (DE) | 1989-01-18 | — | — | EP | claimed |
| EP-0133109-A1 | Process for the N doping of polymers | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1985-02-13 | — | — | EP | claimed |
| US-11827796-B2 | Curable resin composition for three-dimensional shaping and method of manufacturing three-dimensionally shaped product | CANON KABUSHIKI KAISHA (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-112352017-B | Aqueous resin composition and method for producing same | DIC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| WO-2021024894-A1 | AQUEOUS RESIN COMPOSITION AND METHOD FOR PRODUCING SAME | DIC株式会社 | 2021-02-11 | — | — | WO | disclosed |
| EP-0133109-A1 | Process for the N doping of polymers | SOCIETE NATIONALE ELF AQUITAINE (FR) | 1985-02-13 | — | — | EP | disclosed |
| US-4461874-A | Block copolymers of conjugated dienes or vinyl substituted aromatic hydrocarbons and acrylic esters and process for their manufacture | COSDEN TECHNOLOGY, INC. (US) | 1984-07-24 | — | — | US | disclosed |
| EP-0076539-A1 | Block polymers from conjugated dienes or vinyl-substituted aromatic hydrocarbons and acryl esters, and process for their preparation | SOLVAY & Cie (Société Anonyme) (BE) | 1983-04-13 | — | — | EP | disclosed |
| US-4105713-A | GRAFT POLYMERIZING ONTO CHLOROBUTYL RUBBER | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1978-08-08 | — | — | US | disclosed |
| US-4048420-A | ADDITION POLYMERIZATION, BUTADIENE, STYRENE, ISOPRENE, ACRYLONITRILE N | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167626-A1 | Electron transport compound and organic light emitting device comprising the same | TIMM9, SLCO4C1, SLC25A21 | CALM1 3268/4885APP 798/4885TSHR 3970/4885 |
| US-20070244319-A1 | Metallocenyl P-N ligands, preparation thereof, and use for asymmetric catalysis | PNN, PNMT, CPNE4 | CALM1 4749/4885APP 3886/4885TSHR 3129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.